UC San Diego Health System in the US is set to acquire the Nevada Cancer Institute (NVCI) for an undisclosed amount.
The healthcare provider has recieved approval to aqcuire the non-profit institute and will begin to recruit medical and surgical oncologists and search for a physician-scientist to serve as director of the institute. Insight Oncology, a management services organisation, will assist with the integration of the two organisations and provide operational oversight of the facility.
UC San Diego Health System MD and interim CEO Tom McAfee said it was proud to have Nevada Cancer Institute join UC San Diego Health System. "As a world-class health system for cancer and surgical care, UC San Diego is fulfilling its mission of caring for patients locally, nationally, and around the world," he said. "In light of healthcare reform, innovative partnerships between states and their health systems will be key to increasing access to specialised care while managing health care costs."
Opened in 2005, NVCI has treated more than 7,000 patients and provides new treatment strategies through clinical trials, as well as Hope Coach, a mobile mammography unit. NVCI consists of a four-storey, 142,000ft² treatment centre in the Summerlin area of Las Vegas and operates a patient clinic at University Medical Center.
The Institute is also planning to partner with the local medical community and develop collaborations to cater to the needs of local doctors and their patients. UC San Diego Health System said that the acquisition of NVCI has been funded through clinical revenue generated by its hospitals and no state funding was used.
The Health System comprises UC San Diego Medical Center, UC San Diego Thornton Hospital, Moores Cancer Center, Shiley Eye Center and Sulpizio Cardiovascular Center, as well as other primary and speciality practices of UC San Diego Medical Group.